We sought the association between serum Lp(a) and C-peptide levels as two predictors with atherogenic indices of plasma as novel predictive biomarkers and cardiometabolic biomarkers in patients with T2DM based on genders in KERCADR cohort study as an Iranian community. This evidence concerns the gene LPA and type 2 diabetes mellitus.